1. Home
  2. COEP vs KLXE Comparison

COEP vs KLXE Comparison

Compare COEP & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • KLXE
  • Stock Information
  • Founded
  • COEP 2017
  • KLXE 2018
  • Country
  • COEP United States
  • KLXE United States
  • Employees
  • COEP N/A
  • KLXE N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • KLXE Oilfield Services/Equipment
  • Sector
  • COEP Health Care
  • KLXE Energy
  • Exchange
  • COEP Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • COEP 32.0M
  • KLXE 35.8M
  • IPO Year
  • COEP N/A
  • KLXE N/A
  • Fundamental
  • Price
  • COEP $8.03
  • KLXE $2.00
  • Analyst Decision
  • COEP
  • KLXE Hold
  • Analyst Count
  • COEP 0
  • KLXE 1
  • Target Price
  • COEP N/A
  • KLXE $4.50
  • AVG Volume (30 Days)
  • COEP 25.9K
  • KLXE 268.5K
  • Earning Date
  • COEP 08-15-2025
  • KLXE 08-06-2025
  • Dividend Yield
  • COEP N/A
  • KLXE N/A
  • EPS Growth
  • COEP N/A
  • KLXE N/A
  • EPS
  • COEP N/A
  • KLXE N/A
  • Revenue
  • COEP $62,874.00
  • KLXE $688,600,000.00
  • Revenue This Year
  • COEP N/A
  • KLXE N/A
  • Revenue Next Year
  • COEP N/A
  • KLXE $3.97
  • P/E Ratio
  • COEP N/A
  • KLXE N/A
  • Revenue Growth
  • COEP N/A
  • KLXE N/A
  • 52 Week Low
  • COEP $2.31
  • KLXE $1.51
  • 52 Week High
  • COEP $13.70
  • KLXE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • COEP 43.91
  • KLXE 45.93
  • Support Level
  • COEP $6.80
  • KLXE $1.86
  • Resistance Level
  • COEP $8.86
  • KLXE $3.00
  • Average True Range (ATR)
  • COEP 0.62
  • KLXE 0.34
  • MACD
  • COEP -0.05
  • KLXE -0.03
  • Stochastic Oscillator
  • COEP 45.88
  • KLXE 15.97

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: